Evolus, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 7.52 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 496.70M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newpo...